ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RCUS vs BHVN // OPERATING MARGIN

Arcus Biosciences Inc. (NYSE) VS. Biohaven Ltd. (NYSE) • 15-METRIC TALLY: RCUS 1 — BHVN 3
■ METRIC PARITY
operating-margins
-60.00%
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCUS VS. BHVN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RCUS BHVN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -20.42% -24.50% +4.08 RCUS /fcf-yield <GO>
Operating Margin ACTIVE -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -35.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 BHVN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.6 58.4 -26.80 BHVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.32B $2.33B -$13.1M BHVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RCUS REV BHVN REV RCUS GROSS % BHVN GROSS % RCUS FCF BHVN FCF
FY 2025 $33.0M $2.09B — — -$484.0M -$610.2M
FY 2024 $51.0M $2.48B — — -$176.0M -$586.5M
FY 2023 $37.0M $1.22B — — -$306.0M -$331.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCUS // BETA —
BHVN // BETA —